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Abstract
Background:  Campylobacter jejuni infection produces a spectrum of clinical presentations in humans – including
asymptomatic carriage, watery diarrhea, and bloody diarrhea – and has been epidemiologically associated with
subsequent autoimmune neuropathies. This microorganism is genetically variable and possesses genetic mechanisms that
may contribute to variability in nature. However, relationships between genetic variation in the pathogen and variation
in disease manifestation in the host are not understood. We took a comparative experimental approach to explore
differences among different C. jejuni strains and studied the effect of diet on disease manifestation in an interleukin-10
deficient mouse model.
Results: In the comparative study, C57BL/6 interleukin-10-/- mice were infected with seven genetically distinct C. jejuni
strains. Four strains colonized the mice and caused disease; one colonized with no disease; two did not colonize. A
DNA:DNA microarray comparison of the strain that colonized mice without disease to C. jejuni 11168 that caused
disease revealed that putative virulence determinants, including loci encoding surface structures known to be involved in
C. jejuni pathogenesis, differed from or were absent in the strain that did not cause disease. In the experimental study,
the five colonizing strains were passaged four times in mice. For three strains, serial passage produced increased
incidence and degree of pathology and decreased time to develop pathology; disease shifted from watery to bloody
diarrhea. Mice kept on an ~6% fat diet or switched from an ~12% fat diet to an ~6% fat diet just before infection with a
non-adapted strain also exhibited increased incidence and severity of disease and decreased time to develop disease,
although the effects of diet were only statistically significant in one experiment.
Conclusion: C. jejuni strain genetic background and adaptation of the strain to the host by serial passage contribute to
differences in disease manifestations of C. jejuni infection in C57BL/6 IL-10-/- mice; differences in environmental factors
such as diet may also affect disease manifestation. These results in mice reflect the spectrum of clinical presentations of
C. jejuni gastroenteritis in humans and contribute to usefulness of the model in studying human disease.
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Background
Campylobacter jejuni is a major cause of food-borne gastro-
enteritis worldwide. In addition to causing disease in
humans, this microorganism can colonize a variety of
domestic animals, common and exotic pets, and domestic
and wild birds; some of these alternate hosts experience
disease [1,2]. Successful experimental colonization of sev-
eral mouse strains with C. jejuni has been reported, but
disease does not occur unless mice are immunodeficient
or wild type mice are experimentally manipulated [3].
Clinical presentation of campylobacteriosis in human
patients in industrialized countries usually varies from
mild watery diarrhea to severe bloody diarrhea; in devel-
oping countries, milder diarrhea and asymptomatic infec-
tions are also seen [1,2]. Bacteremia can occur. Antecedent
C. jejuni infection has been associated with the develop-
ment of reactive arthritis and the autoimmune neuropa-
thies Guillain Barré and Miller Fisher Syndromes. Disease
expression in humans is likely the result of complex inter-
actions between pathogen genetic properties, host genetic
properties, host physiological state and immune
response, and the host intestinal microbiota [2,4]. Envi-
ronmental factors such as host diet may affect one or more
of these factors; diet variables may act through mecha-
nisms such as modulation of the host immune system by
fatty acids or alteration of the composition of the complex
microbial populations of the lower GI tract [5].
C. jejuni is a genetically variable organism [6]. Over 3000
sequence types are cataloged in the Campylobacter jejuni
Multi Locus Sequence Typing (MLST) database [7], and
numerous studies employing other typing methods such
as restriction fragment length polymorphisms (RFLP) in
an array of genes, amplified fragment length polymor-
phisms, and microarray-based comparisons of entire
genomes have consistently revealed substantial genetic
variation [8-13]. Furthermore, genetic variation has been
documented in a number of virulence determinants,
including genes involved in motility, iron metabolism,
toxin synthesis and secretion, adherence to and invasion
of eukaryotic cells, and capsule and lipo-oligosaccharide
(LOS) synthesis [14-23]. Genetic variation affecting gene
expression has been directly linked to in vivo variation in
pathogenicity of two otherwise very similar strains from
poultry [24].
C. jejuni also possesses mechanisms that could be
expected to generate genetic diversity in vivo. MLST data,
based on analysis of DNA sequences of genes for proteins
of central metabolic pathways, have been used to deduce
that recombination occurs in natural C. jejuni popula-
tions, both within C. jejuni and between C. jejuni and the
closely related C. coli [25-27], although estimates of the
frequency of recombination vary with the method of anal-
ysis used and/or with the type of population studied. De
Boer  et al. [28] demonstrated in vivo genetic exchange
between C. jejuni strains coinfecting chickens. Phase vari-
ation via slip-strand mutagenesis in homopolymeric tracts
has been demonstrated in a motility-related gene [29], a
capsular synthesis gene [18], and a lipo-oligosaccharide
(LOS) synthesis gene [17]. In the latter case, phase varia-
tion results in switching the genes encoding the LOS struc-
ture between forms mimicking GM1 or GM2 gangliosides
found in neural tissue; it is thought that the reaction with
neural tissue of autoimmune antibodies directed against
LOS molecules that mimic neural gangliosides underlies
the development of Guillain-Barré and Miller Fisher syn-
dromes. Prendergast et al. demonstrated in vivo phase var-
iation in the LOS genes in experimentally infected human
volunteers [30].
Evolutionary changes in pathogenicity of pathogens (i. e.,
increase or decrease in virulence) are thought to be the
result of trade-offs between host mortality and probability
of transmission to a new host, although immunopathol-
ogy resulting from damage caused by the immune
response may modulate the selective process [31-33].
Both host and pathogen genetic factors may be important
in the evolutionary process [34]. Serial passage experi-
ments that explore virulence evolution have usually
resulted in increased pathogen-induced damage to the
host [35,36]. A few serial passage experiments have been
conducted with C. jejuni. Fernández et al. [37] showed that
serial intraperitoneal passage in mice of ten C. jejuni
strains that could not invade HEp2 cells in culture
restored and then enhanced this ability, but pathogenicity
of the passaged strains in intestinal infections of mice was
not determined. Chickens are commensally colonized by
C. jejuni and are an important reservoir for human infec-
tion. Ringoir and Korolik [38] showed that serial passage
of four C. jejuni strains in chickens reduced the minimum
infectious dose required for colonization. Jones et al. [39]
showed that passage of a poorly motile variant of C. jejuni
11168 in chickens increased the ability of this strain to
colonize and persist in chickens; this change was accom-
panied by an increase in motility.
Development of a murine model of C. jejuni infection in
which C57BL/6 IL-10+/+ mice are colonized by C. jejuni
11168 while C57BL/6 IL-10-/- mice are both colonized
and experience enteritis allowed us to explore the rela-
tionship between genetic variation in C. jejuni and disease
expression in a model in which host genetic factors are
close to identical and host environmental factors can be
either standardized or varied in a controlled way [40]. Our
first hypothesis was that C. jejuni strains from humans,
chickens, and cattle vary in their ability to colonize and
cause enteritis in C57BL/6 IL-10-/-  mice. Our second
hypothesis was that serial passage of C. jejuni strains inBMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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C57BL/6 IL-10-/- mice would increase the ability of the
passaged strains to cause enteritis in mice. The data
obtained supported both of these hypotheses. Further-
more, during the course of these experiments, it became
apparent that dietary factors can also influence disease
expression in this mouse model.
Results
Five experiments are reported here. Experiment 1 com-
prised genetic comparisons of seven C. jejuni strains by
multilocus sequence typing and restriction fragment pol-
ymorphism analysis of known and putative virulence loci.
Experiment 2 comprised four serial passages of each of
five C. jejuni strains in C57BL/6 IL-10-/- mice. The final
passage in experiment 2 also included (1) a comparison of
passaged strains with unpassaged C. jejuni 11168 and (2)
a comparison of mice infected with unpassaged C. jejuni
11168 kept on an ~12% fat breeder diet and mice infected
with unpassaged C. jejuni 11168 experiencing a transition
from the ~12% fat breeder diet to an ~6% fat maintenance
diet just prior to inoculation. Experiment 3 was suggested
by the results of experiment 2 and comprised a whole ORF
microarray comparison of the gene content of C. jejuni
strains 11168 and NW. Experiment 4 was also suggested
by the results of experiment 2 and comprised a short term
(48 hour) infection study of passaged and unpassaged C.
jejuni 11168 strains to determine whether there were any
differences in ability of the strains to cause enteritis imme-
diately after infection. Experiment 5 was suggested by the
results of the dietary comparison included in the final pas-
sage of experiment 2 and comprised a comparison of mice
infected with unpassaged C. jejuni 11168; mice were kept
on the ~12% fat diet throughout the experiment, were
kept on the ~6% fat diet throughout the experiment, or
were subjected to a transition from the ~12% fat diet to
the ~6% fat diet just prior to inoculation.
C. jejuni strains used in this study were genetically variable 
in both housekeeping genes and virulence determinants 
(experiment 1)
The seven C. jejuni strains used in this study are listed in
Table 1. They represent six MLST sequence types in six
clonal complexes and were chosen in part so as to span
the genetic diversity of the strains characterized by MLST
by Sails et al. [41]. An MLST-based neighbor-joining tree
displaying the genetic relationships of these strains to
each other and to reference strains for the major C. jejuni
clonal complexes is shown in Figure 1A; the tree includes
MLST sequences for reference strains of major clonal com-
plexes established by Wareing et al. [42]. Sequences for
the reference strains and all strains used in this study
except strain NW were obtained from the Campylobacter
jejuni MLST database [7]. MLST typing of strain NW was
carried out in our laboratory (GenBank accession num-
bers FJ361183 through FJ361189) and the clonal complex
determined using the Campylobacter jejuni MLST database.
The two strains that were unable to colonize the mice at
levels detectable by culture (see below) both clustered at a
distance from each other and from the colonizing strains;
the colonizing strains clustered together with the strain
that colonized but did not produce disease.
The seven strains were assayed by polymerase chain reac-
tion (PCR) with gene-specific primers for the presence of
a number of known or putative virulence determinants for
which presence/absence variation had previously been
documented in epidemiological studies (Table 2;
[21,22]). None of the strains were PCR-positive for the
plasmid-borne virB11 gene; as a control for the PCR assay,
we verified the presence of the virB11 gene in strain 81–
176, which carries the pVir plasmid [43]. Strains D2600,
Neighbor-joining trees based on MLST data and RFLP data  for putative virulence determinants (experiment 1) Figure 1
Neighbor-joining trees based on MLST data and 
RFLP data for putative virulence determinants 
(experiment 1). Panel A, MLST; panel B, virulence gene 
RFLP. The MLST tree also includes MLST sequences for ref-
erence strains of major clonal complexes established by 
Wareing et al. [42] obtained from the Campylobacter jejuni 
MLST database [7]. Each strain name is followed by the 
number of the clonal complex to which that strain belongs 
and the source from which it was isolated. The two most dis-
tantly related strains in the virulence gene RFLP analysis, 
D0121 and D2600, had a Jaccard similarity coefficient of 0.45.
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D0835, and NW were PCR-negative for the iam marker;
strain D2600 was also PCR-negative for the wlaN gene.
Restriction fragment polymorphism (RFLP) analysis was
performed on PCR products of the flaA, LOS, cdtABC,
ceuE, pldA, ciaB, dnaJ, and cgtB genes of these strains. The
resulting banding patterns were used to generate the
neighbor-joining tree shown in Figure 1B. The two strains
that were unable to colonize the mice at levels detectable
by culture again clustered at a distance from each other
and from the colonizing strains. Strains 11168 and D2586
were identical in the RFLP analysis of virulence-associated
loci but rather different in MLST. Similarly, strains D2600
and D0835 had very similar RFLP patterns but appeared
in different MLST clusters.
C. jejuni strains differed in their ability to colonize and 
cause enteritis in C57BL/6 IL-10-/- mice in the initial 
passage of experiment 2 (serial passage experiment)
Mice were infected with total doses of ~1 × 1010 cfu C.
jejuni, housed individually for 30–35 days, and then euth-
anized and necropsied as previously described [40]. C.
jejuni cells in wet mounts of all suspensions used to inoc-
ulate mice were highly motile. Mice were evaluated twice
daily for clinical signs of disease and euthanized promptly
if severe clinical signs were observed. Fecal samples were
taken on days 3 or 4, 9 or 10, and at necropsy and spread
on medium selective for C. jejuni (Figure 2). Additional
detailed colonization data are presented in Additional file
1 (Additional file 1, Table S1). As shown in the summary
in Table 3, five of the seven strains were able to colonize
Table 1: Characteristics of Campylobacter jejuni strains used in this study.
C. jejuni strain Species of origin, disease status, location Source MLST sequence type
(clonal complex)
11168 Human disease UK American Type Culture Collection 21
(ST 43)
D2586 Human disease UK Centers for Disease Control 21
(ST 43)
D2600 Human disease USA Centers for Disease Control 353
(ST 452)
D0835 Chicken carrier USA Centers for Disease Control 48
(ST 429)
NW Human disease Africa Sparrow Hospital, Lansing, MI 354
(ST 354)
33560T Bovine carrier USA American Type Culture Collection 403
(ST 403)
D0121 Human unknown Canada Centers for Disease Control 45
(ST 45)
Table 2: Virulence determinants detected by gene-specific PCR assay.
Strain
Gene Function 11168 D2586 D2600 D0835 NW 33560 D0121 Citation
cadF adherence ++++ + ++[16]
cdtABC cytolethal
distending toxin
++++ + ++[21]
ceuE  iron metabolism/
siderophore
++++ + ++[15]
cgtB β-1,3-galactosyl-transferase ++++ + ++[15]
ciaB internalization ++++ + ++[22]
dnaJ heat stress ++++ + ++[22]
flaA motility ++++ + ++[14]
iamB adhesion/invasion ++ - -- ++ [19]
LPS operon lipopolysaccharide ++++ + ++[20]
pldA phopholipase ++++ + ++[22]
racR colonization ++++ + ++[22]
wlaN β-1,3-galactosyl-transferase ++ - + + ++ [17]
Other loci thought to be involved in virulence
luxS global regulator ++++ + ++ This study
virB11 (plasmid) type IV secretion ---- - --[43]BMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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the mice;C. jejuni could be cultured from the feces of 5/5
mice inoculated with strains 11168, D0835, D2586,
D2600, and NW on all days of sampling and from tissue
and fecal samples obtained at necropsy (Figure 2; Addi-
tional file 1, Table S1). Strains 33560 and D0121 were
never recovered by culture from fecal samples taken dur-
ing the course of infection (data not shown) or from tis-
sues or feces collected at necropsy (Additional file 1, Table
S1). Strain 33560 DNA was present at low levels in multi-
ple tissues collected at necropsy as shown by PCR assay for
the C. jejuni gyrA gene [44] performed on DNA extracted
from tissues, but strain D0121 was only weakly detected
in two tissue samples by PCR assay (Additional file 1,
Table S1). Cultures were verified using the same PCR
assay.
Further evidence that strains 33560 and D0121 were una-
ble to persistently colonize the mice is provided by the
fact that while all five of the colonizing strains evoked cir-
culating IgG2b antibody responses, the two non-coloniz-
ing strains evoked little or no antibody as shown in Figure
3. IgG2b accounts for the bulk of the antibody response of
C57BL/6 IL-10-/- mice to C. jejuni [40].
All five colonizing strains were able to cause some gross
pathological changes observed at necropsy, including
enlarged ileocecocolic lymph nodes, thickened colon
wall, and bloody contents in the intestinal lumen (Table
3). The most common gross pathological change was the
occurrence of enlarged ileocecocolic lymph nodes. In pre-
vious experiments, in about one-third of C57BL/6 IL-10-/-
mice infected with non-adapted C. jejuni 11168, the only
gross pathological change observed was an enlarged ile-
ocecocolic lymph node and the histopathology score at
the ileocecocolic junction was ≤ 10 (Grade 0). Four of the
five colonizing strains were able to produce histopatho-
logical changes at the ileocecocolic junction that resulted
in a histopathology score ≥ 10 in at least one mouse in the
initial passage (Table 3). (See [40] for details of the scor-
ing system used. Briefly, the intestinal lumen and three
layers of the intestinal wall (mucosa, lamina propria, and
submucosa) were evaluated separately for indicators of
inflammation such as excess mucus, tissue hyperplasia,
tissue architecture and integrity, infiltration of monocytes
and neutrophils, edema, fibrosis, and vasculitis. Charac-
ters contributed to a score that ranged from 0 to 44; scores
less than 10 were considered normal.)
Three C. jejuni strains caused more severe enteritis 
following serial passage (experiment 2, serial passage 
experiment)
For colonizing C. jejuni strains, the initial results described
above were obtained in the first of four serial passages. For
subsequent passages, C. jejuni growth from cecal tissue of
each individual mouse was harvested and used as the
inoculum for the next serial passage. All of the C. jejuni
growth from the ceca of all mice inoculated with a single
strain was pooled to produce the inoculum for the next
passage. In passages 1 through 3, five mice were inocu-
lated with each C. jejuni strain; ten mice were inoculated
with each strain in passage 4.
As noted below (Materials and Methods), in this series of
experiments, mice in the first passage were inadvertently
shifted from diets containing ~12% fat to ~6% fat just
prior to C. jejuni infection for the first passage. This error
was not discovered until after the mice had been infected.
A previous experiment that allowed a direct comparison
of C. jejuni 11168 infected C57BL/6 IL-10-/- mice on the
~12% fat diet and adapted to the ~6% fat diet for at least
two weeks prior to infection did not reveal a statistically
significant difference in survival, gross pathology or his-
topathology (data not shown). Therefore, all subsequent
Culturable fecal populations of colonizing C. jejuni strains in  C57BL/6 IL-10-/- mice (experiment 2) Figure 2
Culturable fecal populations of colonizing C. jejuni 
strains in C57BL/6 IL-10-/- mice (experiment 2). Levels 
of growth on TSA-CVA agar medium were scored on a scale 
of 0 to 4 (0, no colonies; 1, ≤ ~20 colonies; 2, ~20–200 colo-
nies; 3, ≥ ~200 colonies; 4, confluent growth). C. jejuni was 
not recovered by culture from mice inoculated with tryptose 
soya broth or with non-colonizing strains 33560 and D0121 
at any time. Each point represents an individual mouse.
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passages included a similar dietary shift prior to inocula-
tion in order to maintain constant dietary conditions in
the mice across the four serial passages.
During the first three passages of the serial passage exper-
iment, fecal C. jejuni populations were monitored by plat-
ing on C. jejuni selective medium; population sizes were
scored on a semi-quantitative scale with ranks from 0 to 4
[40] (Figure 2). Briefly, colonization was scored as 0 if
plates had no C. jejuni cfu, level 1 if plates had < 20 cfu,
level 2 if plates had > 20 but < 200 cfu, level 3 if plates had
> 200 cfu, and level 4 if plates were covered with a lawn of
C. jejuni. Two-way ANOVA was performed on the ranked
colonization data from the first three passages with the
Holm-Šidák test for post hoc comparisons. For all strains
except D0835, ranked population sizes varied with the
day of sampling (P = 0.006 for strain 11168, 0.004 for
strain D2586, 0.028 for strain D2600, and 0.009 for strain
NW). In the four strains where significant differences were
found, populations at the time of necropsy in almost all
passages were larger than those on days 3 or 4 and some-
times larger than those on days 9 or 10. For strain 11168,
population sizes on day 3 or 4 were significantly different
from those both on day 9 or 10 and at the time of
necropsy (Pcorrected = 0.01 and 0.02, respectively); popula-
tion sizes on day 9 or 10 were not significantly different
from those at the time of necropsy. Furthermore, signifi-
cant differences in fecal population sizes between pas-
sages were found for strains 11168, D2600, and NW. For
strain 11168, the comparison between passages was sig-
nificant for the comparison of passage 1 to both passages
2 and 3 (Pcorrected = 6.8 × 10-7 and 6.0 × 10-8, respectively)
and for the comparison of passages 2 and 3 (Pcorrected = 1.2
× 10-3). For strains D2600 and NW, only the comparison
between passages 1 and 3 was significant (Pcorrected = 7.4 ×
10-4 and 0.017, respectively).
The fraction of mice harboring C. jejuni in the jejunum
also increased over the serial passage experiments for
strains 11168, D0835, and D2600 (Additional file 1,
Table S1). For strains 11168 and D0835, this fraction
increased from 60% and 40%, respectively, to 100% after
one passage in mice; for strain D2600, this fraction
increased from 60% to 100% between the third and final
passages. The changes in these proportions were signifi-
cant by Fisher's exact test (P = 0.033 for strain 11168; P =
0.004 for strain D0835; P = 0.031 for strain D2600). In
previous experiments, the jejunum was colonized in 30–
60% of mice infected for 28–35 days with unpassaged C.
jejuni 11168 [40]. At the time of necropsy, levels of C.
jejuni colonization in the cecum, the site where C. jejuni
populations are highest and most consistent, were esti-
mated on a semi-quantitative scale [40] and were similar
Table 3: Initial ability of C. jejuni strains to colonize and cause enteritis in C57BL/6 IL-10-/- mice.
C. jejuni strain C. jejuni detectable by 
culture; culture verified by 
PCR
C. jejuni detectable by PCR; 
not detectable by culture
Number of mice having 
gross pathology*
Number of mice having 
histopathology
(score ≥ 10)**
11168 5/5 mice multiple tissues NA*** 1/5 1/5
D2586 5/5 mice multiple tissues NA 2/5 1/5
D2600 5/5 mice multiple tissues NA 2/5 1/5
D0835 5/5 mice multiple tissues NA 2/5 1/5
NW 5/5 mice multiple tissues NA 2/5 0/5
33560 (D0133) 0/5 mice multiple tissues 5/5 mice multiple tissues 0/5 0/5
D0121 0/5 mice multiple tissues 2/5 mice
weak band single tissue
0/5 0/5
* The following gross pathological changes were recorded: enlarged ileocecocolic lymph nodes, thickened colon wall, and presence of blood in the 
intestinal lumen.
** See Mansfield et al. [40] for details of the scoring system used.
*** NA, not applicable.
Plasma levels of anti-C. jejuni IgG2b produced by C57BL/6 IL- 10-/- mice (first passage, experiment 2) Figure 3
Plasma levels of anti-C. jejuni IgG2b produced by 
C57BL/6 IL-10-/- mice (first passage, experiment 2). 
Strains were non-adapted; each bar represents the average 
of five mice; whiskers indicate standard error. TSB, sham 
inoculated control mice.BMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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for all five colonizing strains in all passages (data not
shown).
In the first passage, all mice inoculated with all C. jejuni
strains survived through the entire 30 days of the experi-
ment. In the second passage, some mice inoculated with
strains 11168, D0835, and D2600 required early euthana-
sia due to severe clinical disease (Figure 4). (For details of
clinical scoring protocol, see Michigan State University
(MSU) Microbiology Research Unit Food and Waterborne
Diseases Integrated Research Network-sponsored Animal
Model Phenome Database website http://www.shiga
tox.net/cgi-bin/mru/mi004). In the third passage, some
mice inoculated with these strains and with strain D2586
required early euthanasia. In addition, the time between
inoculation and the development of severe clinical disease
requiring euthanasia decreased steadily over the second
and third passages for strains 11168, D0835, and D2600.
In all passages, all mice inoculated with strain NW sur-
vived for the full duration of the experiment (data not
shown). Kaplan Meier log-rank survival analysis was con-
ducted on the data for each strain from the four passages,
Decrease in mouse survival in four passages during adaptation by serial passage (experiment 2) Figure 4
Decrease in mouse survival in four passages during adaptation by serial passage (experiment 2). Panel A, C. jejuni 
11168; panel B, C. jejuni D0835; panel C, C. jejuni D2600; panel D, C. jejuni D2586. No control mice or mice infected with strain 
NW required early euthanasia (data not shown). All mice in all passages experienced a dietary shift from an ~12% fat diet to an 
~6% fat diet 3 to 5 days prior to inoculation with C. jejuni. Passages 1, 2, and 3 had five infected mice each for each strain; pas-
sage four had 10 infected mice. Passage 1 had four sham inoculated control mice; passages 2 and 3 had five control mice each; 
passage four had 10 control mice.
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although the number of animals (25) in each data set was
low. Results were significant for strain D2600 (P = 0.028)
but not for strains 11168, D2586, or D0835 (P = 0.264,
0.270, and 0.201, respectively). No mice infected with
strain NW required early euthanasia.
The fraction of mice exhibiting gross pathology in the gas-
trointestinal tract on necropsy (enlarged ileocecocolic
lymph nodes, thickened and/or fluid-filled colon, bloody
contents in lumen) increased during serial passage of
three of the five strains. The increased occurrence of
bloody contents in the GI tract lumen was a significant
change from our observations in previous experiments
(Figure 5). The severity of gross pathology, particularly the
fraction of mice exhibiting bloody contents in the intesti-
nal lumen (black sections of bars), increased in passaged
strains 11168, D0835, and D2600 but not in passaged
strains D2586 or NW (Figure 6A–E). In previous experi-
ments, one of 82 C. jejuni 11168 infected C57BL/6 IL-10-
/-  mice had bloody contents in the intestinal lumen
(1.2%), whereas in the second and subsequent passages in
this experiment, 20 of 99 (20.2%) mice infected with pas-
saged strains had this pathology. The single control
mouse (1 of 29) having gross pathology and a high his-
topathology score tested negative for C. jejuni by both cul-
ture and PCR; it was thus a case of spontaneous colitis,
which sometimes occurs in IL-10-deficient mice [45-48].
None of the 19 uninfected C57BL/6 IL-10-/- mice with
spontaneous colitis that we have observed in either our
breeding colony or in experiments have exhibited bloody
contents in the gut lumen. For each passaged C. jejuni
strain, Kruskal Wallis ANOVA was performed to deter-
mine whether differences in the level of gross pathology in
mice from the four different passages of that strain were
statistically significant; results were significant for strain
D2600 (P = 0.047) but not for strains 11168, D2586, or
D0835 (P = 0.099, 0.859, and 0.221, respectively).
Median histopathology scores increased during serial pas-
sage of strains 11168, D0835, and D2600 (Figure 6F–J)
but not strains D2586 and NW. This increase occurred
after the first passage in strains 11168 and D0835 and
after the third passage in strain D2600. The median his-
topathology score rose to over 30 in mice infected with
strains 11168, D0835, and D2600; in previous experi-
ments, the median histopathology score for mice infected
with non-mouse-adapted C. jejuni 11168 ranged from 9
to 19 [40]. Strain D2586 produced high histology scores
in a few mice in the first, third and fourth passages, but the
median score did not rise above 9. For each passaged C.
jejuni strain, Kruskal Wallis ANOVA on ranks was per-
formed to determine whether differences in the level of
gross pathology in mice from the four different passages
of that strain were statistically significant; results were sig-
nificant for strain D2600 (P = 0.044) but not for strains
Changes in gross and histopathology caused by C. jejuni  strains during serial passage (experiment 2) Figure 5
Changes in gross and histopathology caused by C. 
jejuni strains during serial passage (experiment 2). 
C57BL/6 IL-10-/- mice develop typhlocolitis with either 
"watery" contents (primary challenge) or "bloody" contents 
(after adaptation) following oral inoculation with C. jejuni. 
Panels A-D show images of gross pathology; panels E-H show 
images of histopathology from the same mice. Panel A shows 
thickened cecal and colon section with watery contents in a 
C. jejuni infected mouse 30 days after a primary challenge 
with strain 11168. Panels B and D show thickened cecal and 
colon section with bloody contents from a C. jejuni infected 
mouse 30 days after challenge with adapted strain 11168. 
Arrow indicates greatly enlarged ileocecocolic lymph node 
and arrowheads point to cecal tip with dark contents. In D 
cecal tip is opened to expose the frank blood (arrowheads). 
Panel C shows the cecum and colon of a normal sham inocu-
lated control mouse. Panels E-H show histopathology from 
the same mice (E-G images taken at 10× magnification, H 
image taken at 40× magnification). Panel E shows mucosa of 
colon from the C. jejuni infected mouse with watery colon 
contents of Panel A. Note hyperplasia, intense mononuclear 
cell infiltration (white arrows) and slight neutrophilic exu-
dates. Black arrows indicate the presence of intact epithe-
lium. Panel F shows mucosa of colon from C. jejuni infected 
mouse with bloody colon contents from Panels B and D. This 
section also has intense cellular infiltrates, but it also has loss 
of epithelial layer (arrows) and blood and neutrophils present 
in exudates (arrowheads). Panel H shows a close-up of area 
in Panel F indicated with arrows. Long arrows point to 
sloughed villus tip epithelium. Arrowheads point to exudates 
with visible red blood cells and neutrophils. Panel G shows 
the colon mucosa of a normal sham inoculated control 
mouse for comparison.
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Changes in gross and histopathology caused by C. jejuni strains during serial passage (experiment 2) Figure 6
Changes in gross and histopathology caused by C. jejuni strains during serial passage (experiment 2). Panels A-E, 
gross pathology; panels F-H, histopathology. In panels F-H, boxes enclose the central 50% of the scores; whiskers indicate the 
maximum and minimum scores; diamonds indicate the median score. All mice in all passages experienced a dietary shift from an 
~12% fat diet to an ~6% fat diet 3 to 5 days prior to inoculation with C. jejuni. Passages 1, 2, and 3 had five infected mice each 
for each strain; passage four had 10 infected mice. Passage 1 had four sham inoculated control mice; passages 2 and 3 had five 
control mice each; passage four had 10 control mice. ICC, enlarged ileocecocolic lymph node; TW, thickened colon wall; BC, 
bloody contents in GI tract; TSB; sham inoculated control mice.
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11168, D2586, D0835, or NW (P = 0.051, 0.827, 0.130,
and 0.251, respectively). When post hoc multiple compar-
isons on the data for strain D2600 were done using the
Holm-Šidák procedure, the result was significant for the
comparison of histopathology scores of mice in passage 1
compared to the scores of mice in passage 4 (Pcorrected =
0.011).
Histopathology scores were also analyzed using the Man-
tel test for trends with correction for continuity [49]; for
this test, data were cast in a two-way table for each C. jejuni
strain according to the number of the serial passage of the
strain and the number of animals exhibiting lesions of
grades 0 and 1 combined (scores ≥ 0 and ≤ 19) compared
to the number of animals exhibiting lesions of grade 2
(scores ≥ 20). The choice to divide the data in this way for
this analysis was made because of the marked increase
noted above in the median histopathology scores of C.
jejuni  11168 infected mice: from grade 1 in previous
experiments to grade 2 after serial passage. The tests for
trends were statistically significant for strains 11168 (χ2 =
16.47; d.f. = 1; 0.00001 < P < 0.0001), D0835 (χ2 = 18.25;
d.f. = 1; 0.00001 < P < 0.0001), and D2600 (χ2 = 16.90;
d.f. = 1; 0.00001 < P < 0.0001). The test was not significant
for strain D2586 (χ2 = 2.14; d.f. = 1; 0.14 < P < 0. 15) and
could not be conducted for strain NW since there were no
NW-infected mice having histopathology scores in grade
2.
DNA:DNA microarrray comparison of C. jejuni strains 
11168 and NW (experiment 3) revealed differences 
between the strains
Because strain NW was able to colonize C57BL/6 IL-10-/-
mice but did not cause severe enteritis in the initial infec-
tion and did not evolve to a higher level of pathogenicity
during repeated passages, we elected to examine its
genetic content more closely by comparing it to the highly
pathogenic strain 11168 using an in-house full open read-
ing frame (ORF) microarray with coverage of 95% of the
C. jejuni 11168 genome [50]. The microarray was con-
structed using PCR products synthesized using primers for
sequence-validated ORFs developed by Parrish et al. [51]
and genomic DNA from strain 11168 (See NCBIGEO
series number GSE13794 for a description of chip manu-
facture.) We hypothesized that known virulence determi-
nants would be among the genes present in strain 11168
but absent from strain NW.
Sixty-nine C. jejuni 11168 ORFs were identified as possi-
bly absent in strain NW by Genomotyping (GACK) anal-
ysis of microarray data [52]. Fifty-four of the 69 ORFs were
confirmed to be absent or strongly divergent by PCR assay
(Additional file 1, Table S2); PCR products of the appro-
priate size were obtained for thirteen of the remaining
ORFs. Many of the ORFs missing in strain NW belong to
complex loci encoding surface structures known both to
be involved in C. jejuni pathogenesis and to be highly var-
iable in gene content (flagellin, 8 ORFs; capsule, 11 ORFs;
LOS, 1 ORF (gmhA); [53]). Nine additional ORFs may
encode membrane proteins; three may encode DNA
restriction and modification proteins. Four periplasmic
proteins were absent or strongly divergent in strain NW,
along with seven ORFs having other known or putative
functions and 11 ORFs encoding hypothetical proteins for
which no function could be suggested [53].
For two ORFs, Cj 0987c (putative integral membrane pro-
tein) and Cj0874c (possible cytochrome c protein), strain
NW DNA yielded PCR products smaller than those pro-
duced from strain 11168 DNA. Sequencing of the PCR
products from strain NW showed that Cj0987c had a 649
bp deletion (nucleotides 121–770 of Cj0987c from strain
11168) compared to strain 11168. ORF Cj0874c in strain
NW had a 182 bp deletion (nucleotides 212–393 of
Cj0874c from strain 11168) compared to strain 11168.
GenBank accession numbers for these sequences are
FJ361181 and FJ361182.
Early course of infection was not altered by serial passage 
of C. jejuni 11168 (experiment 4; short term infection)
The observation that fecal C. jejuni 11168 population
sizes increased during the course of infection, the signifi-
cant increase in fecal population sizes of this strain with
passage, and the earlier onset of severe enteritis that
occurred during passage of C. jejuni strain 11168 led us to
hypothesize that serial passage might have selected for
variants that were more proficient in growth in the host
immediately after infection and/or in early initiation of
the disease process. Therefore, we infected mice with pas-
saged and unpassaged C. jejuni 11168 and compared lev-
els of colonization, gross pathology, and histopathology
in the two groups 48 hours after infection. The results did
not support the hypothesis. Mice infected with the two
strains did not differ in colonization at different sites in
the GI tract (Additional file 1, Table S1) or in colonizing
population sizes (data not shown). Four of ten mice
infected with unpassaged and four of ten mice infected
with passaged C. jejuni 11168 exhibited slightly enlarged
lymph nodes; all mice had minimal histopathology scores
between 2 and 5 (grade 0; data not shown).
Adaptive humoral immune responses were not consistently 
affected by passage of C. jejuni strains (experiment 2; 
serial passage experiment)
ELISA tests were performed to characterize the adaptive
immune responses of the mice to the evolving strains (Fig-
ure 7A–E); the antigen for all of these assays was prepared
from non-adapted (unpassaged) C. jejuni 11168. The
response of C57BL/6 IL-10-/- mice to C. jejuni was previ-
ously shown to be dominated by Th1-associated antibod-BMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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ies, predominantly IgG2b [40]; the same result was
obtained for the other colonizing strains. There were a few
cases in which anti-C. jejuni IgG subclass antibody titers
were significantly decreased in the serum of mice infected
with the passaged strain in the last passage compared to
the initial passage. Anti-C. jejuni IgA titers were signifi-
cantly lower in mice infected with three of the five pas-
saged strains (11168, D2586, and NW) in the last passage
compared to the initial passage; however, of those three
strains, only C. jejuni 11168 increased in pathogenicity
during passage. Also, anti-C. jejuni 11168 specific IgA
responses of the mice challenged with non-colonizing
strains 33560 and D0121 were high and low, respectively,
suggesting that these responses did not correlate with
clearance of the organism from the GI tract. Although
mucosal IgA responses were not measured, these may bet-
ter correlate with clearance of a particular C. jejuni strain
from the GI tract.
Percentage of fat in and/or fatty acid composition of diet 
influenced disease expression during infection with 
unpassaged C. jejuni 11168 (experiment 2, serial passage 
experiment; and experiment 5, diet comparison)
The two diets fed to the mice in these studies differed prin-
cipally in fat composition (an ~12% minimum for the
breeder diet and an ~6% minimum for the NIH-31 for-
mula maintenance diet) and linoleic acid content (0.62%
for the ~12% fat diet and 2.55% for the ~6% fat diet),
although a number of other constituents were also differ-
ent. Both diets contained wheat, corn, and soybean meal.
The ~12% fat diet also contained porcine fat, whey,
casein, lecithin, and soybean meal and hulls, whereas the
~6% fat diet contained oats, wheat middlings, fish meal,
soybean oil, alfalfa meal, and corn gluten meal. Results
from a previous unrelated experiment did not show any
significant differences in survival, gross pathology, or his-
topathology between groups of C. jejuni 11168 infected
C57BL/6 IL-10-/- mice kept on the ~12% fat diet and mice
kept on the ~6% fat diet throughout the experiment (data
not shown; [54]). However, since mice in that previous
experiment were shifted from the ~12% fat diet to the
~6% fat diet at least two weeks prior to inoculation, the
dietary conditions were not exactly comparable to those
experienced by mice undergoing the dietary transition just
prior to inoculation. Therefore we compared mice
infected with non-adapted C. jejuni 11168 on the ~12%
fat diet and mice experiencing the transition from the
~12% fat diet to the ~6% fat diet in conjunction with the
final phase of the serial passage experiment.
In the diet comparison conducted in the final phase of
experiment 2 (serial passage experiment), six of ten mice
infected with non-adapted C. jejuni 11168 that experi-
enced the transition from the ~12% fat diet to the ~6% fat
diet required early euthanasia due to disease but no mice
infected with non-adapted C. jejuni 11168 and kept on the
~12% fat diet throughout the experiment did so (Figure
8A). Kaplan Meier log rank survival analysis showed that
the difference in survival was statistically significant (P ≤
0.001). Post hoc comparisons were significant for com-
parisons of (1) infected mice on the two diets and (2) con-
trol mice experiencing the transition from the 12% fat diet
to the 6% fat diet to infected mice experiencing the transi-
tion from the ~12% fat diet to the ~6% fat diet at the time
of inoculation (Pcorrected = 0.014 for both comparisons). In
addition, in the diet comparison conducted in the final
phase of experiment 2 (serial passage experiment), there
were significant differences in gross pathology (P = 0.002
for Kruskal Wallis ANOVA; Figure 8C). However, while
mice infected with non-adapted C. jejuni 11168 that expe-
rienced the transition from the ~12% fat diet to the ~6%
Plasma anti-C. jejuni antibody levels in mice infected with dif- ferent C. jejuni strains (experiment 2) Figure 7
Plasma anti-C. jejuni antibody levels in mice infected 
with different C. jejuni strains (experiment 2). Panel A, 
IgG2b; Panel B, IgG2c; panel C, IgG3; panel D, IgG1; and 
panel E, IgA. Antibody levels for the first and fourth passage 
are shown. Bars represent the average OD450/μg plasma pro-
tein of mice in passages 1 and 4; whiskers indicate standard 
error. P values of statistically significant differences between 
antibody level in passage 1 compared to passage 4 for individ-
ual strains are shown on the graph. TSB, sham inoculated 
control mice.BMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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Survival, gross and histopathology in mice on different dietary regimes (experiments 2 and 5) Figure 8
Survival, gross and histopathology in mice on different dietary regimes (experiments 2 and 5). Results from two 
comparisons are shown. One comparison of infected mice on the ~12% fat diet with infected and control mice that experi-
enced a dietary shift from a ~12% fat diet to an ~6% fat diet 3 to 5 days prior to inoculation with C. jejuni was conducted con-
comitantly with the final phase of experiment 2 (serial passage experiment). In experiment 5 (diet comparison), the balanced 
design included control and infected mice kept on the 12% fat diet throughout the experiment, kept on the 6% fat diet 
throughout the experiment, or subjected to a transition from the 12% fat diet to the 6% fat diet just prior to inoculation. No 
sham-inoculated control mice (TSB, tryptose soy broth) required early euthanasia or showed gross pathological changes on 
necropsy; data are not shown. In panel D, boxes enclose the central 50% of the scores; whiskers indicate the maximum and 
minimum scores; diamonds indicate the median score. ICC, enlarged ileocecocolic lymph node; TW, thickened colon wall; BC, 
bloody contents in GI tract; TSB; sham inoculated control mice.
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fat diet were significantly different in gross pathology
from controls experiencing the dietary transition (Pcorrected
= 0.009), the post hoc comparisons of (1) infected mice
on the ~12% fat diet to control mice and (2) infected mice
on the two diets were not significant (Pcorrected = 0.087 and
0.105, respectively). Finally, there were also significant
differences in histopathology (P ≤ 0.001 for Kruskal Wal-
lis ANOVA; Figure 8D) in the diet comparison conducted
in the final phase of experiment 2 (serial passage experi-
ment). In post hoc comparisons, infected mice experienc-
ing the transition from the ~12% fat diet to the ~6% fat
diet at the time of inoculation experienced significantly
greater histopathology (Pcorrected = 0.033) than control
mice experiencing the dietary transition. However, post
hoc comparisons of infected mice on the ~12% fat diet to
(1) infected mice experiencing the dietary transition and
(2) control mice experiencing the dietary transition were
not significant (Pcorrected = 0.057 and 1.0, respectively).
Since different outcomes were observed in two experi-
ments, we conducted another experiment (experiment 5,
diet comparison) with a balanced design that allowed a
full comparison of mice infected with non-adapted C.
jejuni 11168 on three diet regimes (~12% fat diet through-
out, ~6% fat diet throughout, and transition from the
~12% fat diet to the ~6% fat diet just prior to inoculation)
and control mice on each of the three diet regimes. Three
infected mice kept on the ~6% fat diet throughout
required early euthanasia, as did four mice that experi-
enced the transition from the ~12% fat diet to the ~6% fat
diet (Figure 8B). No mice kept on the ~12% fat diet
throughout required early euthanasia. When the survival
curves of the three groups of infected mice were com-
pared, the Kaplan Meier statistic was not significant (P =
0.105).
In experiment 5 (diet comparison), levels of gross pathol-
ogy in infected mice were similar in all groups of mice
(Figure 8C); no control mice exhibited gross pathology.
When gross pathology scores of the six groups of mice
were analyzed using two-way ANOVA on ranked data, dif-
ferences among the groups due to infection status were
significant (Pcontrols vs infected = 6.11 × 10-24), but there was
no statistically significant difference due to diet (P =
0.956), nor was there a statistically significant interaction
between infection status and diet (P = 0.956).
Histopathology scores were elevated both in infected mice
kept on the ~6% fat diet throughout and in infected mice
experiencing the transition from the ~12% fat diet to the
~6% fat diet (Figure 8D). When histopathology scores of
the six groups of mice were analyzed using two-way
ANOVA on ranked data, differences among the groups
due to infection status were significant (Pcontrols vs infected =
2.33 × 10-6), but there was no statistically significant dif-
ference due to diet (P = 0.553). Nor was there a statisti-
cally significant interaction between infection status and
diet (P = 0.611).
Humoral immune responses to C. jejuni infection of mice
on the different dietary regimes in experiment 5 (diet
comparison) are shown in Figure 9. When two-way
ANOVA was conducted on these data, the effect of infec-
tion status (infected vs  controls) was significant for
plasma levels of anti-C. jejuni IgG2b, IgG2c, IgG3, and IgA
(P = 1.68 × 10-10, 8.93 × 10-7, 8.57 × 10-7, and 5.34 × 10-6,
respectively) but not for IgG1 (P = 0.109). There was no
statistically significant effect of diet on levels of anti-C.
jejuni  IgG2b, IgG2c, IgG3, or IgG1 (P = 0.114, 0.203,
0.204, and 0.477, respectively). There was no statistically
significant interaction between diet and infection status
for anti-C. jejuni IgG2b, IgG2c, IgG3, or IgG1 (P = 0.202,
0.075, 0.076, and 0.620, respectively). However, for
plasma anti-C. jejuni IgA, there was a statistically signifi-
cant effect of diet (P = 0.012) as well as a significant inter-
action between diet and infection status (P = 0.035).
Plasma IgA levels were significantly different in mice on
the ~6% fat diet compared to mice on the ~12% fat diet
(Pcorrected = 0.019) and in mice on the ~6% fat diet com-
pared to mice experiencing the transition between the two
diets at the time of inoculation (Pcorrected = 0.032). Plasma
IgA levels in mice experiencing the dietary transition were
not significantly different from those of mice on ~12% fat
diet (P = 0.695).
Discussion
Outcome of infection was influenced by genetic 
differences between C. jejuni strains
MLST analysis of over 3000 strains has provided a com-
prehensive picture of genetic relationships among C.
jejuni strains (Campylobacter jejuni Multi Locus Sequence
Typing website [7]). The seven strains used in this study
represent six different MLST sequence types with varying
degrees of genetic relatedness among them. Genetic rela-
tionships of the seven strains derived from pathogenicity
gene RFLP analysis were roughly consistent with those
derived from MLST data. However, only a small number
of strains were examined, and this congruence may not be
substantiated when more strains are examined. Disease
outcomes were consistent with genetic relationships in
that the two strains that failed to colonize C57BL/6 IL-10-
/- mice clustered at a distance from the colonizing strains
in both MLST and pathogenicity gene RFLP analyses.
However, strains 11168 and D2586 were identical in the
RFLP analysis of virulence loci, and while strain D2586
was able to colonize the mice at high levels and cause
some disease, it did not increase in pathogenicity in the
course of four serial passages. (It is of course possible that
strains D2586 and NW might increase in pathogenicity if
passages were continued.) These results support theBMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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Plasma anti-C. jejuni antibody levels in mice on different dietary regimes (experiment 5) Figure 9
Plasma anti-C. jejuni antibody levels in mice on different dietary regimes (experiment 5). A comparison with a bal-
anced design included infected and control mice kept on the ~12% fat diet, kept on the ~6% fat diet, or experiencing a transi-
tion from the ~12% fat diet to the ~6% fat diet just prior to inoculation. Panel A, IgG2b; Panel B, IgG2c; panel C, IgG3; panel D, 
IgG1; and panel E, IgA. Bars represent the average OD450/μg plasma protein of 10 mice; whiskers indicate standard error. P val-
ues of statistically significant differences between antibody levels are shown on the graph. TSB, sham inoculated control mice.
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hypothesis that there are genetic differences between C.
jejuni strains that can influence the ability of a given strain
to interact with the host. Furthermore, the observation
that there are differences between C. jejuni strains in the
ability to produce enteritis in C57BL/6 IL-10-/- mice shows
that the development of severe disease cannot be solely
attributed to the immune alterations of the mice.
All strains used in these experiments possessed twelve
known and putative virulence loci for which presence/
absence polymorphisms have been reported in the litera-
ture. Two putative C. jejuni virulence determinants, iam
and wlaN, which were absent in one or more of the strains
used in this study, are probably not required for patho-
genicity in mice. The iam marker was first identified as a
DNA fragment obtained in a random amplified fragment
polymorphism analysis; this fragment was epidemiologi-
cally linked to C. jejuni associated disease [19]. However,
another epidemiological study did not reveal a high prev-
alence of this marker in C. jejuni strains from diseased
patients [55], and it has recently been shown that the iam
gene makes little or no contribution to invasion of cul-
tured INT407 cells by C. jejuni strains possessing it [56].
Our results are in accordance with these findings in that
strains D0835 and D2600, which were able to cause
enteritis in C57BL/6 IL-10-/- mice, were iam-. Both the cgtB
and the wlaN genes encode β-1,3- galactosyltransferases
thought to be involved in synthesis of the C. jejuni outer
membrane lipo-oligosaccharide. All strains in this study
possessed  cgtB, and all except D2600 possessed wlaN.
Muller  et al. [57,58] studied the associations of these
genes with the ability to invade Caco-2 cells in culture and
to colonize chickens; their results suggest that possession
of one or both genes is associated with the ability to
invade eukaryotic cells and to colonize the chicken GI
tract, but one strain that lacked both loci was fully inva-
sive.
Adaptation to the host by serial passage altered the 
outcome of infection for three of five C. jejuni strains
Three of five C. jejuni strains (11168, D0835, and D2600)
became more virulent during serial passage in mice as
shown by increased colonization of the jejunum,
decreased time to develop clinical disease, and increased
levels of both gross pathology (particularly increased inci-
dence of bloody diarrhea) and histopathology. Fecal pop-
ulation sizes of two of the three strains that became more
virulent increased during serial passage. The change
toward increased pathogenicity in the three evolving
strains occurred after one passage in two strains and after
three passages in one strain. This observation suggests that
the strain that increased in pathogenicity only after three
passages may have had to undergo more extensive genetic
change than the other two strains. An increase in patho-
genicity is consistent both with a large body of theoretical
work and with previous experimental studies of patho-
genicity evolution; in this case, since the mice were indi-
vidually housed, virulence trade-offs with transmission
dynamics between hosts would not be expected to occur.
Since all mice in all passages of the serial passage experi-
ment experienced the same dietary conditions (transition
from the ~12% fat breeder diet to the ~6% fat NIH-31 for-
mula maintenance diet), differences in the behavior of a
C. jejuni strain in different passages cannot be attributed
to differences in diet, particularly for strain D2600, which
did not show increased colonization of the jejunum or
marked increases in pathology until after the third pas-
sage.
Two C. jejuni strains, D2586 and NW, did not increase in
pathogenicity during four serial passages. Although we
cannot rule out the possibility that continued passage
might have produced an increase in pathogenicity in these
strains, this result shows that the initial genetic comple-
ments of the two strains affected their ability to respond
to the selection pressure imposed by the novel host envi-
ronment of the mouse GI tract.
Microarray comparison of the gene content of strain NW
to that of strain 11168 revealed that strain NW did not
possess a detectable homologue of C. jejuni gmhA, a gene
involved in LOS/LPS synthesis encoding sedoheptulose-
7-phosphate isomerase. This enzyme is essential for pro-
duction of the heptose residues of the inner core of the
LOS/LPS structure. In Haemophilus ducreyi, inactivation of
the gmhA gene has been shown to result in a truncated
LOS and to reduce the ability of the organism to produce
skin lesions in rabbits [59]. In addition, the ability of Sal-
monella enterica to kill Caenorhabditis elegans was impaired
by insertional inactivation of the gmhA gene [60]. Muta-
tion of another C. jejuni gene involved in synthesis of the
LOS inner core, waaC, markedly impaired the ability of C.
jejuni 81–176 to invade the intestinal cell line INT407 in
vitro [61]. Strain NW was also missing a number of C.
jejuni 11168 genes in complex loci involved in capsule
synthesis and O-linked glycosylation of the flagellin pro-
tein. Extensive variation in these loci has been reported in
other microarray comparisons of C. jejuni strains [12].
Both flagella and capsule have been reported to affect vir-
ulence in C. jejuni [18,24]. The reason for the inability of
strain D2586 to increase in virulence is not known, but a
similar approach could be taken to examine gene content
in comparison to strain 11168.
The degree and complexity of the phenotypic changes we
observed – increased fecal population sizes, increased col-
onization of the jejunum, decreased time to develop
severe disease, shift from watery to bloody diarrhea – sug-
gest that the three evolving strains underwent genetic
change at multiple loci, including loci that influenceBMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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growth and loci that influence interaction with and dam-
age to host tissues. We have no information on any spe-
cific genetic changes that led to these phenotypic changes
at the present time; further studies on these strains will
utilize gene expression microarrays to focus on the
hypothesis that the changes in pathogenicity are due to
changes in gene expression levels or patterns; experimen-
tal infection of C57BL/6 IL-10-/- mice with C. jejuni 11168
derivatives containing targeted gene knockouts will be
used to determine whether corresponding genes contrib-
ute to virulence in C. jejuni 11168.
Outcome of C. jejuni infection and host immune response 
were influenced by diet
Results from two of three trials (the previous experiment
with mice kept on an ~12% fat diet and an ~6% fat diet
throughout the experiment and the full, balanced design
comparison (experiment 5, diet comparison) of the effect
of diet on the outcome of C. jejuni infection) did not indi-
cate that there was an effect of diet on survival, gross
pathology, or histopathology in mice infected with unpas-
saged C. jejuni 11168. On the other hand, results from the
diet comparison conducted in the final phase of experi-
ment 2 (serial passage experiment) did indicate such an
effect. In addition, there was a significant effect of diet on
plasma IgA levels in the full, balanced design experiment
(experiment 5, diet comparison). The latter result indi-
cates that some constituent of the diet, possibly the
amount and/or isomeric composition of linoleic acid,
could have affected the immune responses of the mice.
Linoleic acid, which is known to affect the immune
response, was present at ~0.6% in the 12% fat diet and
~2.6% in the 6% fat diet.
The latter results – taken together with the considerable
body of literature implicating specific isomeric forms of
various dietary lipids, including linoleic acid, as immune
system modulators [62,63] at levels comparable to those
in the mouse diets we used [64] and with findings that dif-
ferent dietary lipids can affect the process of infection with
Listeria monocytogenes [64-66] – suggest that dietary fac-
tors, possibly lipid composition, may affect the outcome
of C. jejuni infection in C57BL/6 IL-10-/- mice. The manu-
facturer of the mouse chow we used does not report the
isomeric composition of the total linoleic acid, which is
derived from fish meal, soybean, and grains, and which
might be expected to vary from batch to batch. It would
therefore be difficult or impossible to determine retro-
spectively whether the chow fed to the mice in the three
experiments was different in composition. Finally, it is
also possible that the differing constituents of the two
diets influenced either the host immune system or the
indigenous intestinal microbiota or both in such a way as
to affect the pattern or level of disease expression due to
C. jejuni infection. Experiments using mice fed defined
diets would be required to explore these effects.
There was no indication from the ELISA results that anti-
body responses were protective in C57BL/6 IL-10-/- mice
against infection with any of the tested strains of C. jejuni
used for challenge. The majority of infected mice pro-
duced robust Th1 associated IgG2b responses to all C.
jejuni strains tested; this response was associated with dis-
ease except in strains D2586 and NW. Infected non-colo-
nized mice did not produce strong IgG2b responses. Also,
other antibody responses in plasma of all infected mice
were low. However, there were some significant differ-
ences between the first and last passage in levels of anti-C.
jejuni 11168 IgG2b antibodies detected by ELISA in mice
challenged with various C. jejuni strains. We suspect that
these differences reflected changing surface antigenic
structures of the C. jejuni strains during repeated passage
that made them more or less similar to antigen from the
unadapted 11168 strain used to coat the ELISA plates.
Thus, strain 11168 changed over passage so that mice in
the last passage had significantly less anti-non-adapted
11168 IgG2b antibodies than mice in the first passage.
This speculation would have to be followed up with fur-
ther experiments to test this hypothesis. In contrast, mice
challenged with strain D2586 in the fourth passage pro-
duced IgG2b antibodies that recognized non-adapted
strain 11168 ELISA antigens better than mice in the first
passage experiment. In addition, there was no correlation
between any immunoglobulin isotype and colonization
(rank abundance) of any C. jejuni strain at day 30 after
infection. This result is in contrast to those of Fox et al.
where C57BL129 mice infected with C. jejuni 81–176
cleared their infections 60 days after challenge and clear-
ance was correlated with lower Th1 associated IgG2a
responses [67]. Furthermore, in our dataset it was interest-
ing that in the first round of C. jejuni challenges the high-
est (and most variable) Th2 associated IgG1 responses
were seen in mice receiving the colonizing strains that
caused little or no disease or lesions. A similar pattern was
observed in IgA responses. In mice in groups receiving the
nonpathogenic C. jejuni strains NW and D2586, contin-
ued adaptation of the strain elicited significantly less IgA
and, in the case of D2586, less IgG1. Taken together these
results suggest that there is variability in ability of C. jejuni
strains to elicit Th2 associated immunoglobulins and that
this variability is affected by adaptation to the host,
although the impact of this change on colonization and
disease status is not clear. Further work is needed to exam-
ine anti-C. jejuni strain specific IgA levels in the gastroin-
testinal tract where IgA exerts its main effect.
Conclusion
The results reported here show that C. jejuni strains from
humans, chickens, and cattle vary in their ability to colo-BMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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nize and cause enteritis in C57BL/6 IL-10-/- mice. Further-
more, serial passage of C. jejuni strains in C57BL/6 IL-10-/
- mice as well as dietary factors increase disease expression
in this mouse model. Thus, the C57BL/6 IL-10-/- mouse
model can be used to detect differences in pathogenicity
of different C. jejuni strains and is suitable for screening
clinical isolates from different human disease states or for
screening C. jejuni strains carrying disrupted putative viru-
lence genes. The ORFs identified here as present in C.
jejuni strain 11168 and absent in strain NW will be dis-
rupted and screened for their role in pathogenicity. Fur-
thermore, the model offers the opportunity to dissect the
complex interactions between host genetics, host immune
responses, pathogen genetics, and environmental factors
such as diet and the indigenous microbiota that ulti-
mately determine the course and outcome of infection.
Such studies would clearly enhance investigations of C.
jejuni  virulence mechanisms and perhaps lead to
improved options for prevention and treatment of this
common disease.
Methods
Animals
All animal experiments were conducted according to NIH
guidelines and were approved by the MSU All University
Committee on Animal Use and Care. C57BL/6 IL-10-/-
mice (B6.129P2-IL10tm1Cgn/J) were originally obtained
from the Jackson Laboratories (Bar Harbor, Maine);
breeding mice were maintained and monitored in a spe-
cific-pathogen-free colony at MSU as previously described
[40]. All mice used in these studies were produced in the
on-campus breeding colony. Experiments were conducted
in the University Research Containment Facility at MSU.
Mice were maintained on two diets: irradiated mouse
breeder diet 7904 (~12% fat content) and irradiated
mouse NIH-31 formula maintenance diet 7913 (~6% fat
content) (Harlan Teklad, Indianapolis, IN). Mice were
weaned onto the ~12% fat diet at three weeks of age and
then either kept on that diet, gradually shifted to the ~6%
fat diet at least two weeks prior to inoculation with C.
jejuni at 8 to 12 weeks of age or shifted abruptly to the
~6% fat diet just prior to inoculation at 8 to 12 weeks of
age.
C. jejuni strains
Details concerning the strains used appear in Table 1.
Growth media and inoculum preparation were as previ-
ously described [40].
Genetic methods
Total DNA was extracted from tissue and fecal samples
using DNeasy Tissue Kit (Qiagen, Valencia, CA) and was
assayed by species-specific PCR for the C. jejuni gyrA gene
as previously described [40,44]. Pathogenicity gene com-
plements of the C. jejuni strains were determined using
published PCR assays cited in Table 2; the 9.6 kbp LOS
fragment was generated using the Expand Long Template
PCR System (Roche, Mannheim, Germany). Primers for
luxS were generated using the web-based Primer3 program
[68]   http://jura.wi.mit.edu/rozen/papers/rozen-and-
skaletsky-2000-primer3.pdf: GGTTGTCGCACG-
GGTTTTTA (forward) and GGCAATTTGTTTGGCTTCAT
(reverse). Cycling conditions were 2.0 mM MgCl2, dena-
turation at 95°C for 1 min followed by 30 cycles of 94°C
for 30 s, 49°C for 1 min, 72°C for 2 min, and final exten-
sion at 72°C, 10 min. RFLP analysis of virulence determi-
nants was conducted as follows. PCR products for flaA,
LOS, cdtABC, ceuE, pldA, ciaB, dnaJ, and cgtB were digested
with DdeI, RsaI, or HhaI to generate restriction fragment
length polymorphism (RFLP) patterns. DNA extraction
from bacterial cultures, restriction enzyme digestion, aga-
rose gel electrophoresis, and ethidium bromide staining
were performed using standard methods [69]. Stained gels
were visualized and photographed using an Alpha
Innotech UV transilluminator (Alpha Innotech, San Lean-
dro, CA). Banding patterns were scored visually.
Multilocus sequence typing (MLST) of strain NW (Gen-
Bank accession numbers FJ361183 through FJ361189)
was performed using genes, primer sets, and cycling con-
ditions described at the Campylobacter jejuni Multi Locus
Sequence Typing website http://pubmlst.org/campylo
bacter/ developed by Keith Jolley and Man-Suen Chan
and sited at the University of Oxford [7]. DNA sequencing
was performed at the MSU Genomics Technology Support
Facility. Each PCR product was initially sequenced in both
directions; additional sequencing was done as necessary
to resolve discrepancies.
DNA:DNA microarrray comparison of C. jejuni strains 
11168 and NW
An in-house whole-open-reading frame (ORF) microarray
for C. jejuni 11168 (95% coverage) was developed using
primers and clones described in Parrish et al. [51]. See
NCBIGEO series number GSE13794 for a full description
of chip manufacture. ORFs from pVir, C. jejuni strain 81–
176 were also spotted on the chips. PCR products were
generated from the cloned ORFs using the same primers
and spotted in triplicate on Corning UltraGAP
Superamine slides (Corning, Inc., Corning NY) using an
Affymetrix GeneChip instrument at the MSU Research
Technology Support Facility (RTSF).
Each strain was streaked from frozen stock on two tryp-
tose soya agar plates containing 5% defibrinated sheeps'
blood; plates were incubated for 48 hours at 37°C in 5%
CO2. A single isolated colony from each plate was chosen
and streaked onto another plate (biological replicates).
Growth from each of the second plates was harvested sep-
arately and genomic DNA was isolated using the CTAB
procedure described in Ausubel et al. [69]. One μg DNABMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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was sheared by sonication to 0.5–2.0 kbp and labeled
with aminoallyl-dUTP using the BioPrime random prim-
ing DNA labeling kit® (Invitrogen, Carlsbad, CA). Unre-
acted components were removed using a Qiagen PCR
Purification kit® (Qiagen, Valencia, CA). Aliquots of the
purified aminoallyl-dU-containing DNA were then
reacted with Cy5 or Cy3 dye (Amersham, Piscataway, NJ).
Unreacted dye was removed using a Qiagen PCR Purifica-
tion kit®. The two separate DNA extractions done for each
strain were used in separate hybridizations (technical rep-
licates). The experiment was repeated with the dyes
reversed; thus a total of four chips were hybridized and
compared for each strain. The spots for each gene are
duplicated three times on each chip, for a total of 12 com-
parisons for each strain.
For hybridization, Ambion SlideHyb solution (Ambion,
Austin, TX) was preheated to 54°C. The combined Cy3/
Cy5 labeled DNA samples were resuspended in 4 μl 10
mM EDTA. The sample was then denatured at 95°C for 10
minutes. During this time the cover slip was washed in
95% ETOH, 0.1% SDS and sterile ddH2O. Cover slips
were dried with filtered air. After denaturation of sample,
30  μl of prewarmed Ambion SlideHyb solution was
added. The slides were centered on a warmed hybridiza-
tion cassette and a cleaned cover slip was placed face
down and centered over the spots. The denatured sample
was then gently pipetted using capillary action to fill the
area underneath the cover slip. Sixteen μl of ddH2O was
added to the grooved edge of each hybridization chamber.
The top of the hybridization chamber was then secured;
the slides were placed on a rack in a 54°C water bath over-
night. All steps were performed in the dark.
Post-hybridization washes were performed as follows. In
the dark, the opened cassette was gently moved up and
down in warmed 1 × SSC, 0.2% SDS until the cover slip
fell off. The slide was placed on an orbital platform shaker
at low speed for 4 minutes in the dark. The slide was trans-
ferred to 0.1 × SSC containing 0.2% SDS and incubated
on the platform shaker at low speed for 4 min. The process
was repeated twice with 0.1 × SSC. The slide was placed in
a 50 ml conical tube covered with aluminum foil and cen-
trifuged at 1000 rpm in a clinical centrifuge in a swinging
bucket rotor for 5 min.
The slides were scanned in an Affymetrix 428 scanner and
a "QuickScan" preformed to determine the quality and
intensity of the slide; then the region of interest was
defined and a full scan for Cy5 was done first, Cy5 being
the more "fragile" of the two dyes. Each slide was scanned
with three different gain levels to ensure equal intensity
comparisons in later analyses. The process was repeated
for Cy3. All scans were saved. Images were edited using
GenPixPro3 (Molecular Devices, Sunnyvale, CA). C. jejuni
11168 ORFs were identified as possibly absent in strain
NW based on a relative fluorescence intensity of -0.5 for
strain NW compared to strain 11168 for six of the twelve
spots compared (see Statistical Methods section below).
To confirm the absence of ORFs meeting this criterion,
DNA from strain NW and from C. jejuni 11168 (positive
control) was subjected to PCR assay using the primers
described in Parrish et al. [51]. ORFs for which PCR prod-
uct of the appropriate size was obtained for strain 11168
but for which no PCR product was obtained for strain NW
were considered to be absent or strongly divergent in
strain NW. To verify the identities of some ORFs, PCR
products were partially sequenced at the MSU RTSF using
the same primers used to generate the product on an ABI
Prism® 3100 Genetic Analyzer. Each PCR product was
sequenced in both directions.
Experimental methods and designs
Full details of all experimental methods used in the
murine model of C. jejuni infection are available in Mans-
field et al. [40] and at the MSU Microbiology Research
Unit Food and Waterborne Diseases Integrated Research
Network-sponsored Animal Model Phenome Database
website http://foodsafe.msu.edu/mru_web/MurineEnter
icDiseasesPhenomeDatabase.htm.
For adaptation by serial passage, five mice were inocu-
lated with each C. jejuni strain in the first passage with
inoculum prepared from frozen stock cultures as
described [40]. In the initial passage, a fecal pellet col-
lected from each mouse on days 3 or 4, 9 or 10, and 20 or
21 was suspended in tryptose soya broth (TSB) and
streaked on tryptose soya agar containing 5% defibrinated
sheeps' blood and amphotericin B, vancomycin, and
cefaperazone [40]. Plates were incubated for 48 hours at
37°C in an airtight container with a Campy Gen sachet
(Oxoid, Basingstoke, United Kingdom) and scored for
growth of C. jejuni. Infected mice were necropsied 30 days
after inoculation and C. jejuni populations recovered from
the cecum. For subsequent passages, the inoculum was
prepared using pooled C. jejuni populations from the ceca
of the mice in the previous passage after confirmation that
no contaminants were present. Each strain was used to
inoculate five mice in the second and third passages and
ten mice in fourth and final passage. Four mice in the first
passage, five mice in the second and third passages, and
ten mice in the final passage were sham inoculated with
tryptose soya broth to serve as controls.
For all experiments, 8–12 week old mice were infected
with ~1 × 1010 cfu C. jejuni by oral gavage and observed
daily for clinical signs. Mice were euthanized and necrop-
sied promptly when clinical signs of disease developed or
at thirty days post-infection. Blood samples were obtainedBMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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by cardiac puncture after death. Observations on gross
pathological changes were recorded during necropsy. Tis-
sue snips from stomach, jejunum, cecum, and colon were
spread on agar plates selective for C. jejuni (tryptose soya
agar plates with 5% sheeps' blood and cefaperazone,
amphotericin B, and vancomycin (TSA-CVA) [40]). All of
the C. jejuni growth from cecal tissue of each individual
mouse was harvested from the agar surface and frozen at -
80°C to be used as the inoculum for the next serial pas-
sage. To produce the inoculum for the next passage, each
frozen culture was spread on a tryptose soya sheeps' blood
agar plate with no antibiotics and incubated for 24 hours
at 37°C under a 10:10:80 mixture of H2, CO2, and N2; this
growth was used to inoculate a second plate which was
incubated 12 hours as before. Growth from the second
plate was suspended in broth, and purity and motility
were verified by light microscopy and Gram staining. The
suspension was adjusted to an OD600 of 1.0; the growth
from all plates of a single strain was pooled to produce the
inoculum. Aliquots of each inoculum were suspended in
tryptose soya broth containing 15% glycerol and stored at
-80°C for further studies.
In the first serial passage, mice were inadvertently shifted
from the diet containing an ~12% minimum fat to a diet
containing an ~6% minimum fat just prior to inoculation
with C. jejuni. This error was not discovered until after the
mice had been inoculated. A previous experiment with C.
jejuni infected mice on the ~12% fat diet and ~6% fat diets
did not reveal a statistically significant difference in sur-
vival, gross pathology, or histopathology scores. There-
fore, all subsequent passages included a similar dietary
shift. In an experiment conducted in parallel with the final
passage, 10 mice on the ~12% fat diet and 10 mice that
had experienced the dietary shift were inoculated with
non-adapted (unpassaged) C. jejuni 11168. That experi-
ment did show a statistically significant difference in his-
topathology scores in mice on these two diets, so a third
comparison of diets was done to try to resolve the issue.
Nineteen mice each were kept on the ~12% fat diet,
shifted onto the ~6% fat diet at least two weeks prior to
the experiment, or subjected to the ~12% fat to 6% fat diet
transition 3 to 5 days prior to inoculation as experienced
by the mice in the serial passage experiment. Ten mice in
each of the three diet groups were inoculated with non-
adapted  C. jejuni 11168 and nine mice on each diet
regime were inoculated with tryptose soya broth as con-
trols.
Finally, we conducted a short-term experiment to deter-
mine whether there were differences in events in early
infection between the original and mouse-adapted C.
jejuni 11168 strains. Ten mice each were inoculated with
unpassaged C. jejuni 11168, inoculum prepared from the
C. jejuni 11168 culture used to inoculate the mice in the
fourth (final) passage, or tryptose soya broth. All mice
were kept on the ~12% fat diet throughout this experi-
ment and were necropsied 48 hours after inoculation.
Enzyme-linked immunosorbant (ELISA) assays
Plasma samples were assayed for C. jejuni-specific anti-
bodies as previously described [40] using antigen pre-
pared from non-adapted C. jejuni 11168.
Histopathology
Hematoxylin and eosin stained sections of the ileoceco-
colic junction of each mouse were scored as described pre-
viously on a scale of 0 to 44 [40]. For non-parametric
statistical analysis, this scale was divided into grades of 0
(scores of 0 to 9), 1 (scores of 10 to 19), and 2 (scores of
20 to 44).
Statistical analysis
Cluster analysis based on DNA sequences of housekeep-
ing loci of the C. jejuni strains utilized sequence data from
the  Campylobacter jejuni Multi Locus Sequence Typing
website http://pubmlst.org/campylobacter/[7] and data
generated in our laboratory for strain NW. Alignment and
clustering were performed with ClustalW2 http://
www.ebi.ac.uk/Tools/clustalw/index.html#[70] using
default parameters. Reference strains established by Ware-
ing et al. [42] were also included. Clustering analysis of
manually scored RFLP patterns was performed using the
Cluster V0.1 calculator http://www2.biology.ualberta.ca/
jbrzusto/cluster.php developed by John Brzustowski [71].
The Jaccard similarity coefficient and the Saitou and Nei
neighbor-joining clustering method were used.
Fisher's exact test and the Freeman Halton extension of
Fisher's exact test were performed using the VassarStats
calculator http://faculty.vassar.edu/lowry/Vassar
Stats.html[72].
Kaplan Meier log rank survival analyses were performed
using SigmaStat 3.1 (Systat Software, Port Richmond,
CA).
Gross pathology, histopathology, and ELISA data were
analyzed using SigmaStat 3.1. The nonparametric Kruskal
Wallis one-way ANOVA was used for gross pathology and
histopathology scores in the serial passage experiment.
Scores for analysis of gross pathology data were assigned
as follows: no gross pathology, 1; either enlarged ileoceco-
colic lymph nodes or thickened colon wall, 2; both
enlarged ileocecocolic lymph nodes and thickened colon
wall, 3; enlarged ileocecocolic lymph nodes, thickened
colon wall, and bloody contents in lumen, 4. Kruskal Wal-
lis nonparametric one-way ANOVA was performed on
these scores; if a significant result was obtained, post hoc
comparisons were made using Fisher's exact test. For thisBMC Microbiology 2009, 9:57 http://www.biomedcentral.com/1471-2180/9/57
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test, the two-way table was cast so that mice with no gross
pathology (score of 1) were compared to mice having all
levels of gross pathology (scores 2, 3, and 4) combined;
correction for multiple comparisons was done using the
Holm-Šidák procedure [73]. Histopathology scores were
analyzed as previously described [40]. Two-way ANOVA
and post hoc tests with correction for multiple compari-
sons were used for gross pathology and histopathology
scores in the diet comparison experiment; because scores
were not normally distributed, the analysis was performed
on ranks rather than raw scores.
Histopathology scores from the serial passage experiment
were further analyzed using the Mantel test for trends with
correction for continuity [49]; for this test, data were cast
in a two-way table for each C. jejuni strain according to the
number of the serial passage of the strain and the number
of animals exhibiting lesions of grades 0 and 1 combined
(scores ≤ 19) compared to the number of animals exhib-
iting lesions of grade 2 (scores ≥ 20). The choice to divide
the data in this way for this analysis was made because
almost all of the medians of the histopathology scores of
C57BL/6 IL-10-/-mice infected with non-adapted C. jejuni
11168 for 28–35 days in previous experiments fell into
grade 1 (median scores between 9.5 and 19; [40] and
unpublished data), whereas the median scores of mice
infected with serially passaged C. jejuni 11168 all fell into
grade 2.
ELISA data were transformed as previously described [40]
prior to analysis by one or two-way ANOVA with post hoc
tests using SigmaStat 3.1.
GACK analysis was performed on the microarray data
using programs available at http://falkow.stanford.edu/
whatwedo/software/software.html[52].
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